Related references
Note: Only part of the references are listed.Type III CRISPR-based RNA editing for programmable control of SARS-CoV-2 and human coronaviruses
Ping Lin et al.
NUCLEIC ACIDS RESEARCH (2022)
Antiproliferative effects of AAV-delivered CRISPR/Cas9-based degradation of the HPV18-E6 gene in HeLa cells
Zahra Noroozi et al.
SCIENTIFIC REPORTS (2022)
Targeting NECTIN-1 Based on CRISPR/Cas9 System Attenuated the Herpes Simplex Virus Infection in Human Corneal Epithelial Cells In Vitro
Yue Li et al.
Translational Vision Science & Technology (2022)
Non-homologous dsODN increases the mutagenic effects of CRISPR-Cas9 to disrupt oncogene E7 in HPV positive cells
Weiwen Fan et al.
CANCER GENE THERAPY (2022)
Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6/E7 genes in cervical cancer cells
Rui Tian et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV-1 Infection
Marianna Romito et al.
BIOTECHNOLOGY JOURNAL (2021)
CRISPR/Cas9-loaded stealth liposomes effectively cleared established HPV16-driven tumours in syngeneic mice
Luqman Jubair et al.
PLOS ONE (2021)
Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents
Emmeline L. Blanchard et al.
NATURE BIOTECHNOLOGY (2021)
CRISPR/Cas9-based inactivation of human papillomavirus oncogenes E6 or E7 induces senescence in cervical cancer cells
Raviteja Inturi et al.
VIROLOGY (2021)
CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice
Daniel Stone et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
CRISPR-Cas13a mediated targeting of hepatitis C virus internal-ribosomal entry site (IRES) as an effective antiviral strategy
Muhammad Usman Ashraf et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Aptamers for Anti-Viral Therapeutics and Diagnostics
Tae-Hyeong Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication
Pablo Tebas et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Efficient Inhibition of HIV Using CRISPR/Cas13d Nuclease System
Hoang Nguyen et al.
VIRUSES-BASEL (2021)
Inhibition of Hepatitis B Virus by AAV8-Derived CRISPR/SaCas9 Expressed From Liver-Specific Promoters
Kun Yan et al.
FRONTIERS IN MICROBIOLOGY (2021)
Genome Editing Technologies as Cellular Defense Against Viral Pathogens
Yingzi Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Drugs for the Treatment of Zika Virus Infection
Jean A. Bernatchez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Characterisation of endogenous Claudin-1 expression, motility and susceptibility to hepatitis C virus in CRISPR knock-in cells
Camille M. H. Clement et al.
BIOLOGY OF THE CELL (2020)
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
HEPATOLOGY (2020)
Human Papillomavirus Oncogene Manipulation Using Clustered Regularly Interspersed Short Palindromic Repeats/Cas9 Delivered by pH-Sensitive Cationic Liposomes
Shuai Zhen et al.
HUMAN GENE THERAPY (2020)
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China
David S. Hui et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Timothy R. Abbott et al.
CELL (2020)
Single AAV-Mediated CRISPR-SaCas9 Inhibits HSV-1 Replication by Editing ICP4 in Trigeminal Ganglion Neurons
Yuxi Chen et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
ANKS4B Restricts Replication of Zika Virus by Downregulating the Autophagy
Quanshi Lin et al.
FRONTIERS IN MICROBIOLOGY (2020)
Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing
Yu-Chan Yang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
Cheng-Han Chung et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
A knockdown of the herpes simplex virus type-1 gene in all-in-one CRISPR vectors
Nastaran Khodadad et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2020)
Genome editing of CCR5 by AsCpf1 renders CD4+T cells resistance to HIV-1 infection
Zhepeng Liu et al.
CELL AND BIOSCIENCE (2020)
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
Hongyi Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Improving CRISPR Genome Editing by Engineering Guide RNAs
Su Bin Moon et al.
TRENDS IN BIOTECHNOLOGY (2019)
The HPV-18 E7 CKII phospho acceptor site is required for maintaining the transformed phenotype of cervical tumour-derived cells
Om Basukala et al.
PLOS PATHOGENS (2019)
CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4+ T cells and hematopoietic stem/progenitor cells promotes HIV-1 resistance and CD4+ T cell enrichment in humanized mice
Qiaoqiao Xiao et al.
RETROVIROLOGY (2019)
Systemic Delivery of CRISPR/Cas9 Targeting HPV Oncogenes Is Effective at Eliminating Established Tumors
Luqman Jubair et al.
MOLECULAR THERAPY (2019)
SAMHD1 Regulates Human Papillomavirus 16-Induced Cell Proliferation and Viral Replication during Differentiation of Keratinocytes
Claire D. James et al.
MSPHERE (2019)
Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR
Shili Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth
Haifeng Huo et al.
INFECTIOUS AGENTS AND CANCER (2019)
Programmable Inhibition and Detection of RNA Viruses Using Cas13
Catherine A. Freije et al.
MOLECULAR CELL (2019)
SAMHD1 Suppression of Antiviral Immune Responses
Shuliang Chen et al.
TRENDS IN MICROBIOLOGY (2019)
CRISPR/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6
Takahiro Yoshiba et al.
ONCOLOGY LETTERS (2019)
A Plasmid-Expressed CRISPR/Cas9 System Suppresses Replication of HSV Type I in a Vero Cell Culture
D. S. Karpov et al.
MOLECULAR BIOLOGY (2019)
TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV-1 infection
Ai Qing Yu et al.
MOLECULAR MEDICINE REPORTS (2018)
Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+T Cells via CRISPR/Cas9 Confers Resistance to Both X4-and R5-Tropic Human Immunodeficiency Virus Type 1 Infection
Songlin Yu et al.
HUMAN GENE THERAPY (2018)
Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update
Sherif A. Rezk et al.
HUMAN PATHOLOGY (2018)
Nasopharyngeal carcinoma: A review of current updates
Lei Wu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures
Youdiil Ophinni et al.
SCIENTIFIC REPORTS (2018)
HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies
Shuai Liu et al.
SCIENTIFIC REPORTS (2018)
Zinc-Finger Nucleases Induced by HIV-1 Tat Excise HIV-1 from the Host Genome in Infected and Latently Infected Cells
Haiyan Ji et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute
Yeh-Hsing Lao et al.
ADVANCED SCIENCE (2018)
HPV vaccines - A review of the first decade
Diane M. Harper et al.
GYNECOLOGIC ONCOLOGY (2017)
TALEN-Mediated Knockout of CCR5 Confers Protection Against Infection of Human Immunodeficiency Virus
Bingjie Shi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo
Lei Xu et al.
MOLECULAR THERAPY (2017)
In Vivo Excision of HIV-1 Provirus by saCas9 and Multiplex Single-Guide RNAs in Animal Models
Chaoran Yin et al.
MOLECULAR THERAPY (2017)
RNA targeting with CRISPR-Cas13
Omar O. Abudayyeh et al.
NATURE (2017)
Delivery technologies for genome editing
Hao Yin et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection
Qiankun Wang et al.
RETROVIROLOGY (2017)
Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9
Takeshi Kurihara et al.
SCIENTIFIC REPORTS (2017)
Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection
Zhepeng Liu et al.
CELL AND BIOSCIENCE (2017)
Hepatitis C virus infection
Michael P. Manns et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape
Robert Jan Lebbink et al.
SCIENTIFIC REPORTS (2017)
TALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cells
Sumitra Shankar et al.
SCIENTIFIC REPORTS (2017)
Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-Resistance
Na Zhao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
CRISPR-Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies
Wan-Shun Wen et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Zika Virus and Birth Defects - Reviewing the Evidence for Causality
Sonja A. Rasmussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Editing policy to fit the genome? Framing genome editing policy requires setting thresholds of acceptability
R. Isasi et al.
SCIENCE (2016)
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Omar O. Abudayyeh et al.
SCIENCE (2016)
A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures
Gang Wang et al.
CELL REPORTS (2016)
Zika Virus: Medical Countermeasure Development Challenges
Robert W. Malone et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections
Ferdy R. van Diemen et al.
PLOS PATHOGENS (2016)
Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
Rafal Kaminski et al.
SCIENTIFIC REPORTS (2016)
Inhibition of HSV-1 Replication by Gene Editing Strategy
Pamela C. Roehm et al.
SCIENTIFIC REPORTS (2016)
Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication
Chunsheng Dong et al.
ANTIVIRAL RESEARCH (2015)
Influenza Surveillance: 2014-2015 H1N1 Swine''-Derived Influenza Viruses from India
Kannan Tharakaraman et al.
CELL HOST & MICROBE (2015)
Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome
Xing Liu et al.
JOURNAL OF GENERAL VIROLOGY (2015)
An updated evolutionary classification of CRISPR-Cas systems
Kira S. Makarova et al.
NATURE REVIEWS MICROBIOLOGY (2015)
Damaging the Integrated HIV Proviral DNA with TALENs
Christy L. Strong et al.
PLOS ONE (2015)
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
Weijun Zhu et al.
RETROVIROLOGY (2015)
Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease
Edward M. Kennedy et al.
VIROLOGY (2015)
CRISPR/Cas9-mediated genome editing of Epstein Barr virus in human cells
Kit-San Yuen et al.
JOURNAL OF GENERAL VIROLOGY (2015)
A High Excision Potential of TALENs for Integrated DNA of HIV-Based Lentiviral Vector
Hirotaka Ebina et al.
PLOS ONE (2015)
A Cut above the Rest: Targeted Genome Editing Technologies in Human Pluripotent Stem Cells*
Mo Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection
Weiming Wang et al.
PLOS ONE (2014)
RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
Wenhui Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells
Zheng Hu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
CCR5 Gene Editing of Resting CD4+ T Cells by Transient ZFN Expression From HIV Envelope Pseudotyped Nonintegrating Lentivirus Confers HIV-1 Resistance in Humanized Mice
Guohua Yi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
A ligation-independent cloning technique for high-throughput assembly of transcription activator-like effector genes
Jonathan L. Schmid-Burgk et al.
NATURE BIOTECHNOLOGY (2013)
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
Vikram Pattanayak et al.
NATURE BIOTECHNOLOGY (2013)
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2013)
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Wenyan Jiang et al.
NATURE BIOTECHNOLOGY (2013)
Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells
Xiying Qu et al.
NUCLEIC ACIDS RESEARCH (2013)
Zinc-finger Nuclease Editing of Human cxcr4 Promotes HIV-1 CD4+ T Cell Resistance and Enrichment
Jinyun Yuan et al.
MOLECULAR THERAPY (2012)
FLASH assembly of TALENs for high-throughput genome editing
Deepak Reyon et al.
NATURE BIOTECHNOLOGY (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Reconstruction of the 1918 Influenza Virus: Unexpected Rewards from the Past
Jeffery K. Taubenberger et al.
MBIO (2012)
CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
Elitza Deltcheva et al.
NATURE (2011)
Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting
Tomas Cermak et al.
NUCLEIC ACIDS RESEARCH (2011)
TAL effectors: finding plant genes for disease and defense
Adam J. Bogdanove et al.
CURRENT OPINION IN PLANT BIOLOGY (2010)
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Josiane E. Garneau et al.
NATURE (2010)
Genome editing with engineered zinc finger nucleases
Fyodor D. Urnov et al.
NATURE REVIEWS GENETICS (2010)
Emergence and pandemic potential of swine-origin H1N1 influenza virus
Gabriele Neumann et al.
NATURE (2009)
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Jens Boch et al.
SCIENCE (2009)
Influenza Virus
Johannes Bluemel et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2009)
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Elena E. Perez et al.
NATURE BIOTECHNOLOGY (2008)
Phage response to CRISPR-Encoded resistance in Streptococcus thermophilus
Helene Deveau et al.
JOURNAL OF BACTERIOLOGY (2008)
Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases
Michal Szczepek et al.
NATURE BIOTECHNOLOGY (2007)
Custom zinc-finger nucleases for use in human cells
S Alwin et al.
MOLECULAR THERAPY (2005)
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor
F Li et al.
SCIENCE (2005)
Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin
A Bolotin et al.
MICROBIOLOGY-SGM (2005)
Gene targeting using zinc finger nucleases
MH Porteus et al.
NATURE BIOTECHNOLOGY (2005)
Reactivation of Epstein-Barr virus from latency
W Amon et al.
REVIEWS IN MEDICAL VIROLOGY (2005)
Newly identified host factors modulate HIV replication
YH Zheng et al.
IMMUNOLOGY LETTERS (2005)
CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies
C Pourcel et al.
MICROBIOLOGY-SGM (2005)
Chimeric nucleases stimulate gene targeting in human cells
MH Porteus et al.
SCIENCE (2003)
Share Paper
